Lupus Science & Medicine™ is launched to provide the latest lupus research and stimulate collaborative efforts to improving the lives of all people affected by lupus.
More than 4,000 DC residents participate in the world’s largest lupus walk program
LFA-REAL will address major challenges in lupus treatment and disease management, and has the potential to greatly improve medical care and quality of life for people living with lupus.
Sandra C. Raymond, President and CEO of Lupus Foundation of America, was featured on BioCentury This Week to speak about lupus and the Accelerating Medicines Partnership (AMP). Watch now!
The Lupus Foundation of America will partner with the Foundation for the National Institutes of Health (FNIH) to support a new $230 million, five-year initiative that will accelerate the ability to develop new medicines for lupus and other diverse and complex diseases.
New LIFELINE Grant Will Help Sustain Lupus Research That’s at the Brink of Breakthrough.
The Lupus Foundation of America applauds Congress for enacting the Consolidated Appropriations Act of 2014, H.R. 3547 which provides funding for vital lupus research and education programs.
Cindy Coney, immediate past chair of the Lupus Foundation of America, will be the keynote speaker at the 13th annual North Carolina Lupus Summit in Charlotte. Read more about her story.